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Abstract
Fibroblast growth factor (Fgf) signalling plays a crucial role in many developmental processes. Among the Fgf pathway
ligands, Fgf9 (UniProt: P54130) has been demonstrated to participate in maturation of various organs and tissues
including skeleton, testes, lung, heart, and eye. Here we establish a novel Fgf9 allele, discovered in a dominant N-ethyl-N-
nitrosourea (ENU) screen for eye-size abnormalities using the optical low coherence interferometry technique. The
underlying mouse mutant line Aca12 was originally identified because of its significantly reduced lens thickness. Linkage
studies located Aca12 to chromosome 14 within a 3.6 Mb spanning interval containing the positional candidate genes
Fgf9 (MGI: 104723), Gja3 (MGI: 95714), and Ift88 (MGI: 98715). While no sequence differences were found in Gja3 and Ift88,
we identified an ARG missense mutation at cDNA position 770 of the Fgf9 gene leading to an Y162C amino acid
exchange. In contrast to previously described Fgf9 mutants, Fgf9
Y162C carriers were fully viable and did not reveal reduced
body-size, male-to-female sexual reversal or skeletal malformations. The histological analysis of the retina as well as its
basic functional characterization by electroretinography (ERG) did not show any abnormality. However, the analysis of
head-tracking response of the Fgf9
Y162C mutants in a virtual drum indicated a gene-dosage dependent vision loss of
almost 50%. The smaller lenses in Fgf9
Y162C suggested a role of Fgf9 during lens development. Histological investigations
showed that lens growth retardation starts during embryogenesis and continues after birth. Young Fgf9
Y162C lenses
remained transparent but developed age-related cataracts. Taken together, Fgf9
Y162C is a novel neomorphic allele that
initiates microphakia and reduced vision without effects on organs and tissues outside the eye. Our data point to a role of
Fgf9 signalling in primary and secondary lens fiber cell growth. The results underline the importance of allelic series to
fully understand multiple functions of a gene.
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Introduction
According to the World Health Organization, 315 million
people are visually impaired worldwide. 43 million of them suffer
from complete blindness (,3/60 presenting visual acuity), leading
to a significant loss of life quality and shortened life time. Globally,
the major causes of blindness are (in order of frequency) cataracts,
uncorrected refractive errors, glaucoma, and macular degenera-
tion [1]. However, vision might also be impaired by irregular eye-
size parameters as anterior chamber depth or thickness of the lens.
Microphakia is characterized by smaller lenses and usually occurs
together with other systemic abnormalities inside and outside the
eye as part of the Warburg Micro syndrome (WARBM1; MIM
#600118), Marfan’s syndrome (MFS; MIM #154700), or
rhizomelic chondrodysplasia calcificans punctata (RCDP; MIM
#215100) [2–4]. These syndromes are initiated by mutations in
RAB3GAP (WARMB1; MIM *602536), FBN1 (MFS; MIM
*134797), and PEX7 (RCDP; MIM +601757), respectively [5–9].
Beside these structural and receptor proteins, various members
of the Fgf family play a role in lens growth by regulating
developmental processes. Fgfs are widely expressed in developing
and adult tissues and have diverse functions in organogenesis,
tissue repair, metabolism, and physiological homeostasis. In
humans and mice, 22 Fgf ligands have been described, which
mediate signals through seven different isoforms of Fgf receptors
(FgfRs; reviewed by [10]). At least 13 Fgf ligands are present in the
eye during development and/or at maturity (reviewed by [11]).
Among them, Fgf1 (UniProt: P61148) and Fgf2 (UniProt: P15655)
were initially demonstrated to regulate lens development by studies
in lens epithelial explants [12–14]. In subsequent experiments,
negative effects on lens polarity could be initiated by lens-specific
over-expression of Fg f1 (MGI: 95515), Fg f3 (MGI: 95517), Fg f4
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in the mouse [11,15,16].
Regarding null mutants of these ligands, only Fg f9 knock-out
mice displayed lens pathologies, characterized by delayed primary
lens fiber cell elongation in at least a portion of Fg f9 null embryos
[17]. These Fg f9 knock-out mutants further exhibited various
pathologic phenotypes outside the eye including neonatal lethality
caused by lung hypoplasia and male-to-female sex reversal
initiated by irregular testicular embryogenesis [18–20]. Further-
more, irregular skeletogenesis was detected in an Fg f9
N143T
missense mutant (Fgf9
Eks; MGI: 2182127). This is initiated by an
impaired homodimerization of the altered Fgf9 protein, which
increases diffusion through developing tissues due to decreased
heparin binding affinity of Fgf9
EKS [21,22].
In our attempt to identify novel genes involved in determination
of eye size, we established the mouse mutant line Aca12 (ACMaster
abnormality #12) in a dominant ENU mutagenesis program [23]
because of its significantly thinner lenses compared to data of
control mice [24]. The goal of this study was the genetic and
phenotypic characterization of Aca12. We identified a missense
mutation in the fibroblast growth factor gene Fg f9 as causative
event for the observed microphakia. We further detected reduced
vision in Aca12 and demonstrate a retarded lens growth in Aca12
embryos and postnatal mice. Our study indicates that the novel
Fg f9
Y162C allele has functional (and clinical) consequences different
from other known alleles of Fg f9. Therefore, it shows the
importance of the characterization of allelic series to fully
understand the function of a given gene.
Results
Establishment and genotyping of the Aca12 mouse
mutant line
The mouse mutant line Aca12 was originally detected and
established in a dominant ENU mutagenesis screen for eye size
abnormalities because of its decreased lens thickness (polar
diameter) at the age of 11 weeks (10.1% and 9.4% reduced mean
lens thickness in homozygous Aca12 males and females, respec-
tively). Further investigations revealed an increased anterior
chamber depth and a reduced overall axial length. All eye-size
parameters were less severely affected in heterozygotes, indicating
a semidominant mode of inheritance (Figure 1A and 1B).
Figure 1. Affected eye size parameters of Fgf9
Y162C mutants. (A,B) Mean lens thickness (polar diameter) and axial length were reduced in
heterozygous (A/+, hatched) and homozygous Fgf9
Y162C (A/A, white) mice compared to the C57BL/6J control (WT, black). Anterior chamber depth
was increased in the mutants. (A) females (n=20); (B) males (n=20). *p,0.02; **p,0.001.
doi:10.1371/journal.pone.0023678.g001
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phenotype, we performed a genome-wide linkage analysis by
crossing homozygous mutants on a C57BL/6J background
(G1) to wild-type C3HeB/FeJ mice. Heterozygous mutants
(G2) were backcrossed to C3HeB/FeJ mice. The SNP-based
analysis of 55 G3 offspring revealed linkage of the Aca12
phenotype to chromosome 14 within an interval spanning
13 Mb (between rs13482161 and rs30895903; cytoband C1 to
C3). A further fine mapping using 175 G3 mice located the
Aca12 mutation close to the microsatellite marker D14Mit215,
between rs167842243 and D14Mit234 (Figure 2A). Based on
these data, the genetic order was calculated (genetic distance 6
SD in parenthesis): rs167842243 (1.1560.81 cM), Aca12/
D14Mit215 (0.5760.57 cM), D14Mit234. The critical interval
of approximately 3.6 Mb includes 78 genes. 29 of them are
predicted only because of the existence of ESTs, but are not
yet fully annotated. Among the characterized genes, Gja3 (gap
junction protein, alpha 3), Ift88 (intraflagellar transport 88
homolog [Chlamydomonas]), and Fg f9 have previously been
associated with irregularities in the eye [17,25,26]. Sequence
analysis excluded Gja3 and Ift88 as candidates for Aca12.
However, heterozygous Aca12 carriers exhibited an ARG
transition at cDNA-position 855 of Fg f9 (counting the starting
ATG as position 1; Figure 2B). Since the transition did not
generate a novel restriction site, we confirmed the presence of
this particular mutation in five homozygous carriers by
sequencing of the corresponding region. Moreover, sequence
analysis of four different wild-type strains (C57BL/6J, C3HeB/
FeJ, JF1, and CFW) excluded a general polymorphism at this
site. The 855 ARG transition is predicted to cause an
exchange of Tyr to Cys at amino acid position 162 of the
Fgf9 protein. Consequently, we refer to the novel allele as
Fg f9
Y162C.
Fgf9
Y162C does not affect viability, sex determination, or
skeletogenesis
In order to study whether Fg f9
Y162C carriers are fully viable,
heterozygous individuals were bred to produce homozygous
mutant mice. Among 86 intercross offspring, the genotype
distribution was at the expected Mendelian ratio (25.6%, wild-
types; 47.7%, heterozygotes; and 26.7%, homozygous mutants)
and consequently did not indicate a reduced viability. Regular sex
development in Fg f9
Y162C was proved by sex genotyping PCR. A
Sry signal was generated in all tested heterozygous and
homozygous mutant males. In contrast, none of the female-like
samples showed this signal, excluding the presence of XY
genotyped female-like individuals (Figure 3). Concerning skeleto-
genesis, neither heterozygous nor homozygous Fg f9
Y162C newborn
mice developed elbow joint fusions, knee joint dysplasia, widened
sternums, thickened ribs, fused vertebrae, or fused skull sutures
Figure 2. Haplotype analysis of the Aca12 mutation and sequence analysis of the Fgf9 coding region. (A) The Aca12 mutation is localized
between the flanking microsatellite markers D14Mit268 and D14Mit234. Black boxes illustrate the presence of two C3H marker alleles (recombination
between microsatellite marker and Aca12); white boxes illustrate heterozygosity of the markers for the C3H and C57BL/6J allele (lack of
recombination). The number of G3 progeny carrying the particular recombination pattern is given below the boxes. The total number of
recombination (R) events between neighbouring markers is shown to the right of the boxes, including the calculated relative genetic distances (cM 6
standard deviations). In total, we tested 175 G3 animals. (B) Sequence analysis of genomic DNA of a heterozygous mutant shows an ARG transition
(black arrow) at cDNA position 855 of the Fgf9 gene resulting in a Y162C amino acid exchange in the Fgf9 protein.
doi:10.1371/journal.pone.0023678.g002
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generations, we never observed kinky tails among adult Fg f9
Y162C
mice further demonstrating that skeletogenesis is not affected by
the novel allele Fg f9
Y162C.
Fgf9
Y162C mice show reduced vision that is not caused by
retinal irregularities
Since malformations outside the eye were excluded, we focused
our studies on visual properties and development of ocular tissues.
Vision of Fg f9
Y162C mice was tested in a virtual optokinetic drum
with three-month-old carriers. Calculation of mean spatial
frequency thresholds confirmed a negative effect on vision in both
homozygotes and heterozygotes (Figure 5). One possible reason for
the reduced vision might be an abnormal retinal morphology and
functionality, especially since Fgf9 has been suggested to play a
role in retinal differentiation and maturation [27]. We therefore
analyzed the retina of the more severely affected homozygous
Fg f9
Y162C mice in detail. An initial histological comparison
between Fg f9
Y162C mutants and wild-type controls did not reveal
abnormalities on the cellular level (Figure 6A and 6B). These
findings were confirmed by ophthalmoscopic investigations. All
tested mutants exhibited a homogenously pigmented fundus with a
well defined vessel pattern and a regularly developed optic disc
Figure 3. Fgf9
Y162C mutants exhibit regular sexual develop-
ment. Sex genotyping PCR amplified a Sry fragment (266 bp)
indicating the presence of a Y chromosome in all tested male samples,
but in none of the analyzed female probes. WT, C57BL/6J control (n=5);
A/+, heterozygous Fgf9
Y162C mice (n=6–9); A/A, homozygous Fgf9
Y162C
mice (n=6–12); M, marker.
doi:10.1371/journal.pone.0023678.g003
Figure 4. Skeleton develops regularly in Fgf9
Y162C mutants. (A–E) Alcian blue/Alizarin red staining of (A) elbow joints (lateral view), (B) knee
joints (lateral view), (C) thoraric regions (ventral view), (D) spinal columns (lateral view), and (E) skulls (dorsal view) of C57BL/6J control (WT),
heterozygous Fgf9
Y162C (A/+), and homozygous Fgf9
Y162C (A/A) newborn mice. The mutants did not exhibit skeletal abnormalities. H, humerus; R,
radius; U, ulna; Fe, femur; T, tibia; Fi, fibula; S, sagittal suture; C, coronal suture.
doi:10.1371/journal.pone.0023678.g004
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measurements showed standard implicit times and regular a- and
b-wave amplitudes in the electroretinogram of homozygous
Fg f9
Y162C retinas (Figure 7). It clearly demonstrates that the
function of retinal photoreceptors, bipolar neurons, and ganglions
is not affected as far as can be identified with these methods.
Fgf9
Y162C retards prenatal and postnatal lens growth
We further used the novel Fg f9
Y162C missense mutation to study
the role of Fgf9 signalling during lens development. Comparable
to the recent findings, lens vesicles of embryonic Fg f9
Y162C lenses
remained partly unfilled at E12.5, pointing to retarded primary
lens fiber growth (Figure 8A and 8B). At E15.5, lens fiber cells
elongated completely. However, connection between fibers and
lens epithelium was partly disrupted in the mutants at this
particular stage (Figure 8A and 8B). Further calculations of mean
lens polar and equatorial diameters revealed a significant
reduction of both dimensions in prenatal Fg f9
Y162C lenses
(Figure 8C). Postnatal OLCI measurements confirmed decreased
polar diameters (Figure 9A and 9B). Moreover, postnatal growth
tracking of individual Fg f9
Y162C lenses indicated a significantly
reduced lens growth rate in the tested growth periods (Figure 9C
and 9D).
Reduced lens size did not affect transparency, at least at
younger stages. Histological analysis of four-month-old lenses
confirmed normal nuclear degradation as well as regular lens fiber
cell arrangement and size (Figure 10A–10C). However, 11 out of
18 twelve-month-old mutant lenses exhibited faint opacities of
fiber cells at the anterior pole (Figure 11), indicating a tendency
towards age related cataract formation in Fg f9
Y162C mice.
Fgf9
Y162C does not alter binding affinity for heparin
In order to get first insights into pathologic effects at the protein
level, we performed modeling analysis of Fgf9
Y162C. Structural
changes were not predicted by the 3D-JIGSAW comparative
modeling server (Figure 12A–12C). To test if the affinity towards
heparin is influenced by the mutation Y162C, N-terminally
truncated mFgf9
WT and mFgf9
Y162C were recombinantly ex-
pressed in bacteria and purified to approximately 95% purity. The
proteins were subsequently applied to analytical heparin affinity
chromatography. The major portions of both protein samples
eluted exactly at the same ionic strength (Figure 13A). SDS PAGE
(Figure 13B and 13C) as well as Western Blots (not shown)
Figure 5. Reduced visual acuity in the Fgf9
Y162C mutants. Spatial
frequency thresholds indicated a reduced vision in the Fgf9
Y162C
mutants. Values represent means 6 standard deviation of measure-
ments from twelve C57BL/6J controls (WT), ten heterozygous Fgf9
Y162C
mutants (A/+), and ten homozygous Fgf9
Y162C carriers (A/A). *p,0.001.
doi:10.1371/journal.pone.0023678.g005
Figure 6. Regular retinal histology and fundus morphology of Fgf9
Y162C mutants. (A,B) Morphology of four-month-old C57BL/6J control
(WT) and homozygous Fgf9
Y162C (A/A) retinas (A) and optic nerve heads (B) are compared. The mutants displayed a regular retinal development. (C)
Funduscopy of six-month-old C57BL/6J controls (WT) and homozygous Fgf9
Y162C (A/A) mice also revealed a regular pigmentation, optic disc structure,
and blood vessel pattern in the eye fundi of the mutants. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer
plexiform layer; ONL, outer nuclear layer; IS/OS, inner segment/outer segment of photoreceptor layer; RPE, retinal pigment epithelium.
doi:10.1371/journal.pone.0023678.g006
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effect on the heparin binding affinity.
Discussion
We have established the novel mouse mutant Aca12 that is
primarily characterized by changes of ocular structures, e.g. larger
anterior chambers, thinner lenses, and shorter axes. A genome
wide linkage analysis and fine mapping placed the mutation on
chromosome 14 within a 3.6 Mb interval. Sequence studies of
positional candidate genes identified a base pair exchange within
the Fg f9 gene (chromosome position 58.69–58.73 Mb); this
mutation co-segregates with the phenotype among our breeding
colony and was not found within other wild-type strains of mice.
The facts that (i) a recombination between the Aca12 mutation and
D14Mit215 (chromosome position 58.99 Mb) did not occur
among 175 G3 carriers of the linkage study, (ii) the 855 ARG
transition co-segregates with the phenotype and does not occur as
a polymorphic site in other mouse strains, and (iii) Fg f9 has
previously been associated with ocular malformations [17] further
support the conclusion that the 855 ARG mutation represents the
causative event for the observed pathologic phenotypes.
The replaced tyrosine residue 162 in Fgf9 is conserved between
mice and humans and is an essential component of one of the 12 b
strands defining the FGF trefoil fold; it is present also in FGF16
(UniProt: O43320) and FGF20 (UniProt: Q9NP95; they form
together with FGF9 [UniProt: P31371] one of the FGF subfamilies
[28]). Pathologic missense mutations in FGF9 (MIM #600921)/
Fg f9 have been identified in humans affecting amino acid position
99 (S99N [29]) and position 143 in mice (N143T [22]). Among
other features, in both cases, skeletal malformations have been
described; however, effects on the skeleton have not been identified
in the new Fg f9
Y162C allele. Nevertheless, we demonstrate for the
first time an essential role of this conserved residue Tyr-162 for the
functional integrity of the Fgf protein. Position 162 is localized close
to essential residues of the heparin binding site [30]. However,
experimental data with recombinant proteins suggest no influence
of the mutation on the heparin binding affinity.
Because of the unique phenotype, the novel Fg f9
Y162C allele
represents most likely a dominant-negative or neomorphic
mutation, since the pathological phenotype is present in the
heterozygotes. This feature is different from the recessive mode of
inheritance in the Fg f9 knockouts; these heterozygotes are
phenotypically normal [18]. However, similar to our new
Fg f9
Y162C allele, the Fg f9
Eks allele (characterized by a N143T
substitution [22]) is also characterized by a dominant mode of
inheritance [21]. In contrast to our new Fg f9
Y162C allele, the
Fg f9
Eks allele leads to several skeletal defects. The molecular
explanation includes the prevention of homodimerization of
Fgf9
Eks, a reduced binding affinity to heparin [22], and increased
diffusion properties. Therefore, Fgf9
Eks is present in regions, where
it usually does not occur; this ectopic Fgf9 signalling represses
skeletal joint and suture development [21]. In contrast to Fgf9
Eks,
the regular skeletogenesis, the viability of the homozygous mutants
and the regular sex determination in Fg f9
Y162C mutants strongly
points to a different pathologic mechanism in these mutants.
To understand the role of homodimerization, Kalinina et al.
[28] introduced structure-based mutations into the dimer
interfaces of FGF9 (D195A, L200A, I204A, L205A). The
corresponding mutant proteins occur more frequently as a
monomer, exhibit enhanced proliferative activities, and bind
heparin more weakly than wild-type Fgf. It would be of great
interest to see whether the novel Fg f9
Y162C allele leads to similar
biochemical consequences.
Since the resulting pathologic symptoms are restricted to
decreased eye sizes and reduced visual properties, we focused
our detailed analysis on the ocular function. Since ERG and
retinal histology were normal in the mutants, reduced vision is
obviously not caused by irregular development of retinal layers or
optic nerve head. Consequently, the altered ocular structures of
the Fg f9
Y162C mutants characterized by deeper anterior chambers
(about 4%), thinner lenses (about 10%), and shorter axes (about
5%) might be responsible for the reduced vision. Moreover,
reduced vision might be due also to irregular development of
visual system in the brain, since Fg f9 also is expressed in the visual
cortex [31].
Our histological studies of embryonic Fg f9
Y162C lenses indicated
a retarded growth of primary lens fibers, since the lens vesicle of
the mutants remained only partly filled at E12.5. This is in
accordance with previous findings in Fg f9 null embryos [17]. We
Figure 7. Fgf9
Y162C mice exhibit regular functionality of the retina. Electroretinograms of six-month-old C57BL/6J control (WT) and
homozygous Fgf9
Y162C (A/A) mice are shown. The mutants exhibit a regular electrical response to the given light flashes. (A), a-wave amplitude; (B), b-
wave amplitude.
doi:10.1371/journal.pone.0023678.g007
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Y162C on
postnatal lens growth. Since secondary lens fiber cells are of
regular shape and thickness, equatorial diameter of Fg f9
Y162C
lenses is most likely reduced because of a decreased total number
of fiber cell layers. This would point to an essential role of Fgf9
signalling in proliferation of lens epithelial cells and fiber cell
differentiation, respectively. Moreover, the reduced lens polar
diameter might further indicate effects of Fg f9
Y162C on lens fiber
elongation. The decreased number of fiber cell layers does not
affect transparency of the young lens, but about half of the tested
lenses developed age-dependent polar opacifications.
Considering the confirmed role of Fgf9 signalling in lens
development, it seems surprising that ocular Fg f9 expression is
restricted to retinal layers [17,32,33]. It therefore seems very likely
that Fgf9 is secreted by retinal cells and diffuses through the
vitreous to the lens. This would further explain the requirement of
Figure 8. Retarded primary lens fiber growth and reduced size of the Fgf9
Y162C prenatal lens. (A,B) Lens morphology of (A) C57BL/6J
control (WT) and (B) homozygous Fgf9
Y162C (A/A) lenses is shown at E12.5/E15.5. Growth of primary lens fibers is retarded in the mutants at E12.5. At
E15.5, connection between lens fibers and lens epithelium is partly disrupted (arrows). L, lens; NR, neural retina; C, cornea. (C) Mean lens polar and
equatorial diameter calculation at E12.5/E15.5 indicated a reduced size of both dimensions in the homozygous mutants. Values are means 6
standard deviation (n=5). *p,0.01.
doi:10.1371/journal.pone.0023678.g008
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account that an increased diffusion of Fgf9
Y162C can be excluded as
discussed above, retarded lens growth might consequently be the
result of reduced Fgf9
Y162C concentrations in the lens tissue due to
decreased diffusion abilities. This hypothesis is further supported
by dose dependent effects of Fgf9 on lens development. In
particular, transgenic overexpression of Fgf9 resulted in severe lens
defects including irregular polarity and postnatal cataract
formation [16]. Loss of Fgf9 function in homozygous knockout
mutants initiated mild lens pathologies [17] which can be
compared to the situation in heterozygous Fg f9
Y162C mutants.
However, completely different pathologic mechanisms (like altered
receptor binding affinity) underlying the irregular lens develop-
ment in Fg f9
Y162C can currently not be excluded; polarity of lenses
might develop normally because of an Fgf9
Y162C concentration
gradient. This hypothesis would fit to previous results that indicate
an essential role of FGF gradients on determining anterior-
posterior patterns of the lens [34,35].
The target genes of Fgf9 signalling during lens development
remain to be identified. Effects on lens fiber maturation have
previously been described in various gap junction protein mutants
including connexin23 (UniProt: Q9CX92), connexin43 (UniProt:
P23242), connexin46 (UniProt: Q64448), and connexin50 (Uni-
Prot: P28236) [36–39]. Similar to the situation in homozygous
Fg f9
Y162C mice, irregular cell-to-cell appositions between lens
epithelial cells and fiber cells were found in the connexin23- and
connexin43 mutants [36,37]. It seems very likelythat Fgf9 signalling
interacts withgap junction protein expression in the lens. Since Fgf9
binds specifically to the Fgf receptors 2 and 3 [40], studies using
conditional knockout mice lacking Fgf receptor expression further
provided hints for putative Fgf9 signalling targets. Triple knockout
mice (Fg fr1–3; MGI: 95522–95524) exhibited irregular lens fiber
elongation and proliferation together with aberrant or reduced
expression of p27
kip1 (UniProt: P46414), p57
kip2 (UniProt: P49919),
Prox1 (UniProt: P48437), Pax6 (UniProt: P63015), c-Maf (UniProt:
P54843), E-cadherin (UniProt: P09803), and crystallins (UniProt:
P24622, P02525, and P04345) [41].
In conlcusion, the Fg f9
Y162 mouse line described here provides
a novel Fg f9 allele with yet unknown properties. It will be useful
for getting more insights into the role of Fgf9 signalling in lens
development; moreover, our data suggest FGF9 as a candidate for
human age-related cataracts. Since the new Fg f9 allele leads to a
novel phenotype not observed in other of FGF9 mutants, it is of
great interest to uncover the underlying biochemical differences.
Materials and Methods
Ethics statement
The use of animals was in accordance with the German Law of
Animal Protection, the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research, and the tenets of the
Declaration of Helsinki. Animal experiments of this study were
approved by the ethics committee of the Upper Bavarian
government (TVA #55.2-1-54-2531-78-06).
Figure 9. Decreased Fgf9
Y162C lens thickness at postnatal stages and retarded postnatal lens growth in Fgf9
Y162C mutants. (A,B) Mean
lens thickness (polar diameter) of homozygous Fgf9
Y162C mutants (dashed lines) obtained by OLCI at different postnatal stages are compared to the
C57BL/6J control data (solid lines). Mutants exhibit significantly reduced lens sizes at all tested stages. (A) females; (B) males. (C,D) Postnatal lens
growth of homozygous Fgf9
Y162C mice (white bars) and C57BL/6J controls (black bars) is tracked by OLCI. In the mutants, lens growth is most
strikingly reduced at early postnatal stages. (C) females; (D) males. Values are means 6 standard deviation (n=10–12). *p,0.01; **p,0.001.
doi:10.1371/journal.pone.0023678.g009
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Mice were kept under specific pathogen-free conditions at the
Helmholtz Center Munich. Male C57BL/6J mice were treated
with ENU (80 mg/kg body weight applied by intraperitoneal
injection in three weekly intervals) at the age of 10–12 weeks as
previously described [42] and mated to untreated female C57BL/
6J mice [23]. The offspring of the ENU-treated mice were
screened at the age of 11 weeks for abnormalities of the eye size
[24]. Mice with phenotypic deviations were tested for a dominant
mode of inheritance.
Linkage analysis
Heterozygous carriers (first generation) were mated to wild-type
C3HeB/FeJ mice, and the offspring (second generation) were
backcrossed to wild-type C3HeB/FeJ mice. DNA was prepared
from tail tips of affected offspring of the third generation (G3). For
genome-wide linkage analysis, genotyping of a genome-wide
mapping panel consisting of 149 single nucleotide polymorphisms
(SNP) was performed using MassExtend, a MALDI-TOF (matrix-
assisted laser/desorption ionization, time of flight analyzer) mass
spectrometry high-throughput genotyping system supplied by
Sequenom (San Diego, CA, USA; [43]). Fine mapping was
performed with the microsatellite markers D14Mit141, D14Mit101,
D14Mit142, D14Mit268, D14Mit215,a n dD14Mit234.F u r t h e r m o r e ,
recombination frequency between Aca12 and the SNP rs167842243
(chromosome 14, genome coordinates 56,682,854) was determined
Figure 10. Regular equatorial lens histology and fiber cell size of Fgf9
Y162C mutants. (A,B) Morphology of (A) four-month-old C57BL/6J
control (WT) and (B) homozygous Fgf9
Y162C (A/A) lenses is shown. The mutants display a regularly developed lens bow. L, lens; R, retina. (C) Mean lens
fiber cell thickness at the age of four months calculated by averaging the breadth of ten fiber cell layers in the equatorial outer cortex. Lens fiber cell
size did not differ significantly in the homozygous Fgf9
Y162C mutants. Values are means 6 standard deviation (n=5).
doi:10.1371/journal.pone.0023678.g010
Figure 11. Age-related cataract formation in Fgf9
Y162C lenses.
C57BL/6J control (WT) and homozygous Fgf9
Y162C (A/A) lenses are
compared at three different stages (two, six, and twelve months of age).
All lenses remained transparent at least up to six months of age. Some
twelve-month-old mutant lenses developed an age-related polar
cataract (arrow).
doi:10.1371/journal.pone.0023678.g011
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subsequent sequence analysis.
Genotyping, sex determination, and sequencing
Genomic DNA was isolated from tail tips of C57BL/6J,
C3HeB/FeJ, JF1, and CFW wild-type mice or homozygous/
heterozygous mutants according to standard procedures.
PCR of the mutated site was performed with the primers Fgf9-
IV-1 and Fgf9-IV-2, sex genotyping PCR was carried out with the
primers Sry-1 and Sry-2 amplifying the sex determining region of
chromosome Y (Table 1). For sequencing of promising candidate
genes, the primer pairs Fgf9-I/Fgf9-II, Gja3-I/Gja3-II, and Ift88-I
to Ift88-VIII were used (Table 1).
PCR was performed with a PTC-225 thermocycler (MJ
Research, Waltham, USA). Products were analyzed by electro-
phoresis on a 1.5% agarose gel. Sequencing was performed
commercially (GATC Biotech, Konstanz, Germany) after direct
purification of the PCR products (Nucleospin Extract II,
Macherey-Nagel, Du ¨ren, Germany).
The coding sequence of the novel Fgf9
Y162C allele is available
under GenBank accession HM988990.
Protein modeling
The PDB files used to model Fgf9
WT and Fgf9
Y162C was
generated from the 3D-JIGSAW comparative modeling server
[44]. The proteins were modeled using the 3D Mol-Viewer
component of the Vector NTI Suite software 9.0.0 (Invitrogen,
Darmstadt, Germany).
Fgf9 bacterial expression, purification and heparin
binding
Fgf9
WT and Fgf9
Y162C were expressed and purified essentially
as previously described [22,45]. Residues 34 to 208 each of
mFgf9
WT and mFgf9
Y162C were cloned into the vector pET28a(+)
(Novagen, Darmstadt, Germany) between NcoI and HindIII sites.
Forward primer mFgf9for-33a_NcoI and reverse primer
mFgf9rev_HindIII were used (Table 1). The resulting open
reading frames coded for proteins of ,20 kDa. Sequence
integrity was verified by Sanger sequencing. Plasmid constructs
were transformed into E.coli BL21 DE3 (Stratagene, Waldbronn,
Germany) and protein expression was induced by 0.5 mM IPTG
in LB/Kan medium for four hours at 37uC or overnight at 20uC.
Bacteria were harvested, suspended in lysis buffer (25 mM
HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM EDTA,
protease inhibitor Complete [Roche, Mannheim, Germany]) and
subsequently disrupted by lysozyme treatment and sonication.
DNA was digested by DNaseI (New England Biolabs, Frankfurt,
Germany). After removal of cell debris by centrifugation,
ammonium sulfate was added to the supernatants to reach 25%
saturation. After centrifugation Fgf9 proteins were precipitated
over night from the supernatant at 50% saturation of ammonium
sulfate. Pellets were dissolved in 40 volumes 25 mM HEPES
pH 7.5, 120 mM NaCl, centrifuged, and the supernatants
applied to a 1 ml HiTrap heparin affinity column (GE
Healthcare, Little Chalfont, United Kingdom). Proteins were
eluted with a linear gradient (120 mM to 2 M NaCl) in HEPES
pH 7.5. Fractions containing enriched mFgf9 proteins were
applied to a second round of heparin affinity chromatography.
Identity of mFgf9 proteins was verified by SDS-PAGE and
Western blotting (polyclonal antibodies from Antibodies-Online,
Aachen, Germany). Protein concentration of purified proteins
was determined by Bradford assay (Bio-Rad, Mu ¨nchen, Ger-
many) using BSA as standard.
Analytical heparin affinity chromatography
1.5 mg each of ,95% pure mFgf9
WT and mFgf9
Y162C were
loaded onto a 1 ml HiTrap heparin HP column (GE Healthcare,
Little Chalfont, United Kingdom) equilibrated with 25 mM
Figure 12. Predictive modeling of the Fgf9
Y162C protein. (A) The lateral view on Fgf9
WT structure shows that the exchanged amino acid
residue (red arrow) lies close to essential residues of the heparin binding region (marked in yellow). (B,C) Dorsal view on the wild-type protein (B) and
Fgf9
Y162C (C) indicates that structural changes within the heparin binding region (yellow marked residues) are not predicted. The amino acid residues
at position 162 are marked in red.
doi:10.1371/journal.pone.0023678.g012
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were eluted with a linear gradient of NaCl (120 mM to 2.0 M) in
the same buffer.
Skeleton preparation
Newborn mice were eviscerated and the skin was removed.
After fixation in 100% ethanol (four days) and incubation in
Figure 13. Affinity for Fgf9
WT and Fgf9
Y162C to heparin. (A) Chromatographic analysis of the affinities of mFgf9
WT and mFgf9
Y162C for heparin is
shown. mFgf9
WT and mFgf9
Y162C were loaded onto a HiTrap heparin column (1.5 mg each) and eluted with a linear gradient of NaCl from 120 mM to
2.0 M (conductivity line). Elution profiles of mFgf9
WT (red) and mFgf9
Y162C (blue) were determined by monitoring absorbance at 280 nm. (B,C)
Coomassie stained SDS-PAGE gels monitoring the chromatographic analysis for mFgf9
WT (B) and mFgf9
Y162C (C). Std, standard; appl, sample load; RT,
run through; fr, fraction.
doi:10.1371/journal.pone.0023678.g013
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blue/Alizarin red solution (150 mg Alcian blue solved in 50 ml
70% ethanol, 50 mg Alizarin red solved in 50 ml 95% ethanol,
50 ml acetic acid, 850 ml 100% ethanol) for ten days. After
staining, mice were washed, cleared in 1% KOH/20% glycerol
(two weeks), and stored in 100% glycerol.
Histological preparation, embryonic lens area
determination, and mean lens fiber cell thickness
calculation
Eyes of embryos and adult mice were histologically analyzed for
retinal irregularities, lens area, and lens fiber cell pathologies.
Embryo heads or separated eyes were fixed for seven days in
Davidson solution and embedded in JB-4 plastic medium
(Polyscience Inc. Eppelheim, Germany) according to the manu-
facturer’s protocol. Sectioning was performed with an ultramicro-
tome (OMU3; Reichert-Jung, Walldorf, Germany). Serial trans-
verse 3-mm sections were cut with a glass knife and stained with
methylene blue and basic fuchsin. The sections were evaluated
with a light microsocope (Axioplan, Carl Zeiss, Jena, Germany).
Images were acquired by means of a scanning camera (AxioCam;
Jenoptik, Jena, Germany) and imported into an image-processing
program (Photoshop 10.0, Adobe, Unterschleissheim, Germany).
Embryonic lens diameters and lens fiber cell sizes were analyzed
using the size determination tools provided by the AxioVision
4.6.3.0 software (Carl Zeiss, Jena, Germany). Mean lens fiber cell
thickness was calculated by averaging the breadth of ten fiber cell
layers in the equatorial outer cortex.
Lens growth determination and eye size measurement
The sizes of ocular parameters were examined between four
and 15 weeks of age using optical low coherence interferometry
(OLCI; ‘‘ACMaster’’, Meditec, Carl Zeiss, Jena, Germany).
Briefly, mice were anesthetized with an intraperitoneal injection
of 137 mg ketamine and 6.6 mg xylazine per kilogram body
weight. The anesthetized mouse was placed on a platform and
Table 1. PCR primers used in this study.
Short name Sequence Product size Tm
SNP56.68-1 59-GCAAATAAAGTTTGCATGACCA-39 63.5uC
SNP56.68-2 59-TTTGGAGCTGAGACGAAAGG-39 398 bp 64.3uC
Fgf9-IV-1 59-TTGAAGACTATTCTGGTTCAAAGA-39 60.6uC
Fgf9-IV-2 59-CAAAGTTTGGCAACAGTGGA-39 471 bp 63.7uC
Sry-1 59-GAGAGCATGGAGGGCCAT-39 65.3uC
Sry-2 59-CCACTCCTCTGTGACACT-39 266 bp 55.8uC
Fgf9-I-1 59-TCGCCTAGTGTCTCCTGGTT-39 63.7uC
Fgf9-I-2 59-GACCAGGCCCACTGCTATAC-39 398 bp 63.4uC
Fgf9-II-1 59-CGGTACTATCCAGGGAACCA-39 63.6uC
Fgf9-II-2 59-CAACAGTGGAGCTGAGGTGA-39 497 bp 64.2uC
Gja3-I-1 59-GGAATCCAGCACTGTCAGGT-39 54.0uC
Gja3-I-2 59-GCATGAAGATGACAAAGATGG-39 700 bp 50.0uC
Gja3-II-1 59-AGGCCCACAGAGAAGACCAT-39 54.0uC
Gja3-II-2 59-GGAATCCAGCACTGTCAGGT-39 791 bp 54.0uC
Ift88-I-1 59-ATCAGGCGTCGCTTCTTC-39 63.1uC
Ift88-I-2 59-TGATGTCAGGGATGTCTTGG-39 297 bp 63.6uC
Ift88-II-1 59-ATCAGGCGTCGCTTCTTC-39 63.1uC
Ift88-II-2 59-CTTTCTTCTCCAACTGTCTAATTTTT-39 499 bp 60.8uC
Ift88-III-1 59-ATTTGACCCCCTTGGTCAGT-39 64.4uC
Ift88-III-2 59-TTTATGGACACTTGGGATCTGA-39 469 bp 63.1uC
Ift88-IV-1 59-GCAATGCAGGAAGACTGAAA-39 62.9uC
Ift88-IV-2 59-CAAAAGACGCTTCGATCACA-39 498 bp 63.9uC
Ift88-V-1 59-AAGGAAAGCCATGGCAGAA-39 64.4uC
Ift88-V-2 59-TCCAGACGGTTCAGCTTCTT-39 495 bp 63.9uC
Ift88-VI-1 59-AGAGGCCCTGAGAAACGACT-39 64.2uC
Ift88-VI-2 59-AGCTACCATCAGCTGCCACT-39 460 bp 63.9uC
Ift88-VII-1 59-TGCGAGAAAGCCATTCAGTA-39 63.4uC
Ift88-VII-2 59-TTCTATCTGAGGGCCCAGTG-39 486 bp 64.1uC
Ift88-VIII-1 59-CAAAGAAATAGATGCCTCCTACG-39 62.6uC
Ift88-VIII-2 59-AAGTTCCAGGCCAGAGGAA-39 250 bp 63.7uC
mFgf9for-33aa_NcoI 59-TTTCCATGGATGGACCACCTGGGTCAG-39 47.4uC
mFgf9rev_HindIII 59-TTTAAGCTTTCAGCTTTGGCTTAGAATATC-39 474 bp 48.5uC
doi:10.1371/journal.pone.0023678.t001
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infrared LEDs arranged in a circle that must be placed in the
center of the pupil. Central measurements of lens thickness (polar
diameter), axial length, corneal thickness, and anterior chamber
depth as well as data evaluation were performed essentially as
described [24,46].
Virtual vision test
Vision tests were performed between 9 am and 4 pm using a
virtual optomotor system (Cerebral Mechanics, Lethbridge,
Canada) as described previously [47]. Briefly, a rotating cylinder
covered with a vertical sine wave grating was calculated and
drawn in virtual three-dimensional space on four computer
monitors facing to form a square. Visually unimpaired mice track
the grating with reflexive head and neck movements (head-
tracking). Vision threshold of the tested mice was quantified by a
simple staircase test. Rotation speed and contrast were set to
12.0 d/s and 100%, respectively. Since no significant threshold
differences were observed between males and females (P.0.05;
calculated by Mann-Whitney U-test), data of both sexes were
combined. Thresholds of wild-type C57BL/6J and homozygous
Fg f9
Y162C mice were compared using the Mann-Whitney U-test.
Funduscopy
Nine-month-old mice with clear lenses were administered 1%
atropine to each eye to dilate their pupils. The fundus examination
was performed with a Heine Sigma 150K indirect ophthalmoso-
cope (Haag-Streit GmbH, Wedel, Germany) and a Volk 90D
superfield lens (Haag-Streit GmbH). Digital fundus images were
taken with a Heine Video Omega 2C indirect ophthalmoscope
connected to a VRmAVC Video Grabber (Dieter Mann GmbH,
Mainaschaff, Germany) and a Volk 40D or 60D lens (Fronha ¨user
GmbH, Unterhaching, Germany). The images were imported in
an image-processing program (Photoshop 10.0; Adobe).
Elektroretinography (ERG)
Ganzfeld ERGs were recorded simultaneously from both eyes of
six-month-old mice to examine the retinal function as described
[48]. In brief, mice were dark-adapted for at least 12 hours and
anaesthetized. After pupil dilation (1 drop Atropine 1%),
individual mice were fixed on a sled and gold wires (as active
electrodes) were placed on the cornea. The ground electrode was a
subcutaneous needle in the tail; a reference electrode was placed
subcutaneously between the eyes. The mice were introduced into
an ESPION ColorBurst Handheld Ganzfeld LED stimulator
(Diagnosys LLC, Littleton, MA, USA) on a rail to guide the sled
(High-Throughput Mouse-ERG, STZ for Biomedical Optics and
Function Testing, Tu ¨bingen, Germany). 10 ms light pulses were
delivered at a frequency of 0.48 Hz and a light intensity of
12,500 cd/m
2. Responses were recorded with an ESPION
Console (Diagnosys LLC, Littleton, MA, USA).
General
Chemicals were from Merck (Darmstadt, Germany) or Sigma
Chemicals (Deisenhofen, Germany).
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